Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations

Dengue fever has been a worldwide concern, with 50-100 million new infections each year mainly due to five different serotypes of the Dengue virus (DENV). Designing a perfect anti-dengue agent that can inhibit all the serotypes by distinguishing antigenic differences is quite difficult. Previous anti-dengue researches have included chemical compounds screening against DENV enzymes. The ongoing analysis is meant for investigation of the plant-based compounds as antagonistic to DENV-2 focusing on the specific NS2B-NS3Pro target, a trypsin like serine protease that cuts the DENV polyprotein into separate proteins crucial for viral reproduction. Initially, a virtual library of more than 130 phytocompounds was prepared from previously published reports of plants with anti-dengue properties, which were then virtually screened and shortlisted against the WT, H51N and S135A mutant of DENV-2 NS2B-NS3Pro. The three top-most compounds were viewed as Gallocatechin (GAL), Flavokawain-C (FLV), and Isorhamnetin (ISO) showing docking scores of -5.8, -5.7, -5.7 kcal/mol for WT, -7.5, -6.8, -7.6 kcal/mol for the H51N, and -6.9, -6.5, -6.1 kcal/mol for the S135A mutant protease, respectively. 100 ns long MD simulations and MM-GBSA based free energy calculations were performed on the NS2B-NS3Pro complexes to witness the relative binding affinity of the compounds and favourable molecular interactions network. A comprehensive analysis of the study reveals some promising outcomes with ISO as the topmost compound with favourable pharmacokinetic properties for the WT and mutants (H51N and S135A) as well, suggesting as a novel anti-NS2B-NS3Pro agent with better adapting characters in both the mutants.Communicated by Ramaswamy H. Sarma.

[1]  Madhusmita Panda,et al.  Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies , 2022, Journal of Molecular Modeling.

[2]  Madhusmita Panda,et al.  Functionalized carbon nanotubes as an alternative to traditional anti-HIV-1 protease inhibitors: An understanding towards Nano-medicine development through MD simulations. , 2022, Journal of molecular graphics & modelling.

[3]  Madhusmita Panda,et al.  Structure-based virtual screening, ADMET profiling, and molecular dynamics simulation studies on HIV-1 protease for identification of active phytocompounds as potential anti-HIV agents , 2022, Molecular Simulation.

[4]  V. Orekhov,et al.  1H, 13C and 15N resonance assignment of backbone and IVL-methyl side chain of the S135A mutant NS3pro/NS2B protein of Dengue II virus reveals unique secondary structure features in solution , 2022, Biomolecular NMR assignments.

[5]  Qi Zhang,et al.  Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332 , 2021, Protein & Cell.

[6]  M. Rahman,et al.  Antiviral phytochemicals as potent inhibitors against NS3 protease of dengue virus , 2021, Comput. Biol. Medicine.

[7]  A. Poso,et al.  Ligand Accessibility Insights to the Dengue Virus NS3‐NS2B Protease Assessed by Long‐Timescale Molecular Dynamics Simulations , 2021, ChemMedChem.

[8]  N. Mishra,et al.  An Effective MM/GBSA Protocol for Absolute Binding Free Energy Calculations: A Case Study on SARS-CoV-2 Spike Protein and the Human ACE2 Receptor † , 2021, Molecules.

[9]  Sharoen Yu Ming Lim,et al.  Recent insights on anti-dengue virus (DENV) medicinal plants: review onin vitro,in vivoandin silicodiscoveries , 2020, All Life.

[10]  Marco Tutone,et al.  Exploring the SARS-CoV-2 Proteome in the Search of Potential Inhibitors via Structure-Based Pharmacophore Modeling/Docking Approach , 2020, Comput..

[11]  Priyanka Sharma,et al.  Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants , 2020, Journal of biomolecular structure & dynamics.

[12]  Chitra Jeyaraj Pandian,et al.  Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials , 2020, Journal of biomolecular structure & dynamics.

[13]  P. Agback,et al.  Probing contacts of inhibitor locked in transition states in the catalytic triad of DENV2 type serine protease and its mutants by 1H, 19F and 15 N NMR spectroscopy , 2020, BMC Molecular and Cell Biology.

[14]  A. Sonawane,et al.  Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp) inhibition: an in-silico analysis , 2020, Journal of biomolecular structure & dynamics.

[15]  Reaz Uddin,et al.  Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach , 2020, Journal of biomolecular structure & dynamics.

[16]  S. Kang,et al.  Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease , 2019, Scientific Reports.

[17]  S. Robledo,et al.  In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting , 2019, BMC Complementary and Alternative Medicine.

[18]  Ihsan Ikhtiarudin.  Synthesis and in Silico Studies of a Benzenesulfonyl Curcumin Analogue as a New Anti Dengue Virus Type 2 (DEN2) NS2B/NS3 , 2019, Indonesian Journal of Pharmacy.

[19]  R. Yusof,et al.  Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling , 2019, PloS one.

[20]  H. Wahab,et al.  Potential anti-viral compounds from Malaysian Plant Natural Product Repository and Database (MyNature50000) for DENV2 , 2019, Biotechnology & Biotechnological Equipment.

[21]  Evan Bolton,et al.  PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..

[22]  Waqar Hussain,et al.  Computational exploration of antiviral activity of phytochemicals against NS2B/NS3 proteases from dengue virus , 2018, Turkish Journal of Biochemistry.

[23]  Duncan R. Smith,et al.  Activity of andrographolide against dengue virus , 2017, Antiviral research.

[24]  W. Setzer,et al.  An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever , 2016, Combinatorial chemistry & high throughput screening.

[25]  Serdar Durdagi,et al.  Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study. , 2016, Journal of molecular graphics & modelling.

[26]  Lukasz Kurgan,et al.  Unstructural biology of the dengue virus proteins , 2015, The FEBS journal.

[27]  Y. Leo,et al.  Dengue Serotype-Specific Differences in Clinical Manifestation, Laboratory Parameters and Risk of Severe Disease in Adults, Singapore , 2015, The American journal of tropical medicine and hygiene.

[28]  Yixuan Wang,et al.  Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism. , 2015, Journal of molecular graphics & modelling.

[29]  S. Sekaran,et al.  Effects of cocktail of four local Malaysian medicinal plants (Phyllanthus spp.) against dengue virus 2 , 2013, BMC Complementary and Alternative Medicine.

[30]  Daniel R Roe,et al.  PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.

[31]  Jie Shen,et al.  admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..

[32]  Biswa Ranjan Meher,et al.  Binding of single walled carbon nanotube to WT and mutant HIV-1 proteases: analysis of flap dynamics and binding mechanism. , 2012, Journal of molecular graphics & modelling.

[33]  Holger Gohlke,et al.  MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.

[34]  Daniel Hoffmann,et al.  The Normal-Mode Entropy in the MM/GBSA Method: Effect of System Truncation, Buffer Region, and Dielectric Constant , 2012, J. Chem. Inf. Model..

[35]  Biswa Ranjan Meher,et al.  Interaction of I50V mutant and I50L/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir): molecular dynamics simulation and binding free energy studies. , 2012, The journal of physical chemistry. B.

[36]  N. Meanwell.  Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. , 2011, Chemical research in toxicology.

[37]  Zhiming Yuan,et al.  Identification of palmatine as an inhibitor of West Nile virus , 2010, Archives of Virology.

[38]  Tingjun Hou,et al.  Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. , 2007, Journal of medicinal chemistry.

[39]  G. Vriend,et al.  Fast empirical pKa prediction by Ewald summation. , 2006, Journal of molecular graphics & modelling.

[40]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[41]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[42]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[43]  D. Case,et al.  Modification of the Generalized Born Model Suitable for Macromolecules , 2000 .

[44]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[45]  M S Mustafa,et al.  Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. , 2015, Medical journal, Armed Forces India.

[46]  D. Goodsell,et al.  Automated docking of substrates to proteins by simulated annealing , 1990, Proteins.